Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

AIMS--To make a preliminary assessment of the clinical relevance of serum vitronectin concentrations in various disease groups, using a recently available commercial radial immunodiffusion kit. METHODS--Serum vitronectin concentrations were measured in 80 control subjects and 144 patients with various diseases. The following characteristics were used to evaluate the test procedures: linearity of method, inter- and intrabatch precision, effect of storage, temperature and in vitro activation of the classical and alternative complement pathways on vitronectin concentrations. RESULTS--Significantly reduced serum vitronectin concentrations were found in patients with liver disease, renal disease, and systemic lupus erythematosus (SLE) (normal C3 and C4 concentrations, when compared with normal subjects. This particular method was suitable for measuring vitronectin concentrations in serum samples provided they were stored at -20 degrees C. CONCLUSIONS--The clinical value of measuring serum vitronectin seems to be limited, but a larger study may be justified to ascertain the clinical importance of reduced serum vitronectin concentrations in liver diseases, and the possible role of vitronectin in other disease processes.

[1]  K. Tanikawa,et al.  Vitronectin in liver disorders: Biochemical and immunohistochemical studies , 1992, Hepatology.

[2]  D. Jenne,et al.  Structure of Vitronectin and its Biological Role in Haemostasis , 1991, Thrombosis and Haemostasis.

[3]  R J Falk,et al.  Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. , 1991, The Journal of investigative dermatology.

[4]  S. Bhakdi,et al.  [Functions and relevance of the terminal complement sequence]. , 1990, Immunitat und Infektion.

[5]  K. Preissner,et al.  Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. , 1989, Blood.

[6]  B. Dahlbäck,et al.  Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. , 1989, The Journal of investigative dermatology.

[7]  Fibronectins and Vitronectin , 1989, The Lancet.

[8]  T. Mollnes,et al.  S‐Protein Is Synthesized by Human Monocytes and Macrophages in Vitro , 1989, Scandinavian journal of immunology.

[9]  K. Preissner,et al.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. , 1988, Clinical and experimental immunology.

[10]  D. Mosher,et al.  Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. , 1988, Blood.

[11]  S. Katayama,et al.  Three types of vitronectin in human blood. , 1988, Cell structure and function.

[12]  K. Preissner,et al.  S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3 , 1987, European journal of haematology.

[13]  K. Yamada,et al.  Immunological characterization of human vitronectin and its binding to glycosaminoglycans. , 1986, Journal of biochemistry.

[14]  B. Dahlbäck,et al.  Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. , 1986, The Journal of biological chemistry.

[15]  K. Preissner,et al.  S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin. , 1986, European journal of biochemistry.

[16]  D. Jenne,et al.  Molecular cloning of S‐protein, a link between complement, coagulation and cell‐substrate adhesion. , 1985, The EMBO journal.

[17]  K. Preissner,et al.  Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.

[18]  E. Ruoslahti,et al.  A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Dahlbäck,et al.  Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. , 1985, Biochemistry.

[20]  D. Jenne,et al.  Monoclonal antibodies to human plasma Protein X alias complement S-protein , 1985, Bioscience reports.

[21]  T. Foley,et al.  Quantitation of spreading factor in human biologic fluids. , 1984, The Journal of laboratory and clinical medicine.

[22]  E. Ruoslahti,et al.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Engvall,et al.  Cell attachment on replicas of SDS polyacrylamide gels reveals two adhesive plasma proteins , 1982, The Journal of cell biology.

[24]  K. Stenn,et al.  Epibolin: a protein of human plasma that supports epithelial cell movement. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Heldin,et al.  Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor. , 1981, Science.

[26]  H. Müller-Eberhard,et al.  Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. , 1979, The Journal of biological chemistry.

[27]  L. Fryklund,et al.  Primary structure of somatomedin B A growth hormone‐dependent serum factor with protease inhibiting activity , 1978, FEBS letters.

[28]  R. Holmes PREPARATION FROM HUMAN SERUM OF AN ALPHA-ONE PROTEIN WHICH INDUCES THE IMMEDIATE GROWTH OF UNADAPTED CELLS IN VITRO , 1967, The Journal of cell biology.

[29]  W. Sun,et al.  Polymorphism of vitronectin. , 1989, Blood.

[30]  E. Ruoslahti Fibronectin and its receptors. , 1988, Annual review of biochemistry.

[31]  K. Miyazaki,et al.  The culture of human tumor cells in serum-free medium. , 1981, Methods in enzymology.